SA Pathology sends CSF specimens for the highly-specialised Alzheimer test to the National Dementia Diagnostics Laboratory (NDDL) at the University of Melbourne.From 28 February, the NDDL will commence using the Roche Generation II (GII) CSF assay for detection of Alzheimer’s disease(β-Amyloid (1-42), Phospho Tau, Total Tau), requiring a significant change to the specimen collection requirements:
SA Pathology will maintain a supply of blue capped tubes (Sarstedt 63.614.625) at the Royal Adelaide Hospital, The Queen Elizabeth Hospital, Lyell McEwin Hospital and Flinders Medical Centre.
Refer to the NDDL collection protocol for AD: Biomarker assay in Fresh CSF (GII) information sheet for more information about test collection.
All CSF specimens must be accompanied by a completed Specimen Data Sheet. Please contact the on-call clinical microbiologist on 8222 3123 if you have any questions.
Regards, A/Prof Tom DoddClinical Service Director